CROFABIOTECH
Main Vertical
BioTech
CEO/FOUNDER
Name and Surname
Dr.Adrián Mutto
Linkedin Profile or Bio
Name and Surname
Dr.Adrián Abalovich
Linkedin Profile or Bio
Name and Surname
Mariela Balbo
Linkedin Profile or Bio
Number of people on the Staff
8
Legal Form
Public Limited Company (SA)
Year of Founding
2022
Type of Company
Startup
Development Stage
Validation
Province
City of Buenos Aires
City
Capital Federal
Main Business Model
B2B
Problem
The company focuses on medical challenges related to organ dysfunction, seeking solutions that improve patients' quality of life through the application of gene-editing technologies. Currently, they are developing the generation of organs for xenotransplantation, specifically hearts and kidneys.
Solutions Offered - Summary
Gene editing, xenotransplantation, advanced stem cells.
Solutions Offered - Details
Crofabiotech develops innovative biotechnology solutions, including gene editing for the enhancement of human organs, the generation of modified pig organs for xenotransplantation, and embryonic stem cell lines. It also offers R&D services for disease studies, drug testing, and human health advancements.
Technologies Used
Big Data or Data Analytics, Web Platform
Counterparties of Interest abroad
Financing, Incubators
Industries served
Health
International Presence
UNITED STATES
Investment Round:
Series A
Awards/Recognitions
15th edition of the Banco Nación – Empretec Foundation Innovative Solutions Competition.
Presentation
E-mail
info@crofabiotech.com